SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-Sep-24 4:08 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Sep-24 | Sale | 192 | $36.21 | $6,951.55 | (< 1%) 38.33K to 38.14K | |
18-Mar-24 4:19 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Mar-24 | Private Sale | 184 | $56.46 | $10,388.80 | (< 1%) 39.07K to 38.88K | |
23-Jan-24 6:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Jan-24 | Private Sale | 1,061 | $65.00 | $68,960.80 | (3%) 40.13K to 39.07K | |
17-Jan-24 4:45 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Grant | 8,312 | -- | -- | 25% 32.68K to 40.99K | |
17-Jan-24 4:45 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Sale | 864 | $66.81 | $57,722.60 | (2%) 40.99K to 40.13K | |
24-Oct-23 4:20 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 23-Oct-23 | Market Sale | 132 | $46.04 | $6,076.78 | (< 1%) 32.81K to 32.68K | 3% |
18-Sep-23 4:20 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Sep-23 | Grant | 2,500 | -- | -- | 8% 30.31K to 32.81K | |
01-Sep-23 4:08 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 31-Aug-23 | Market Sale | 551 | $41.23 | $22,715.50 | (2%) 30.86K to 30.31K | (8%) |
22-Feb-23 6:44 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Grant | 4,044 | -- | -- | 15% 27.15K to 31.2K | |
22-Feb-23 6:44 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Payment of Exercise | 334 | $58.50 | $19,539.00 | (1%) 31.2K to 30.86K | |
24-Jan-23 4:58 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Jan-23 | Payment of Exercise | 919 | $52.05 | $47,833.90 | (3%) 28.07K to 27.15K | |
17-Jan-23 7:26 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 12-Jan-23 | Grant | 9,621 | -- | -- | 52% 18.45K to 28.07K | |
24-Oct-22 5:09 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Oct-22 | Payment of Exercise | 130 | $58.00 | $7,540.00 | (< 1%) 18.58K to 18.45K | |
31-Aug-22 4:26 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 30-Aug-22 | Payment of Exercise | 558 | $58.84 | $32,832.70 | (3%) 19.14K to 18.58K | |
25-Jan-22 4:36 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Jan-22 | Grant | 6,974 | -- | -- | 82% 8.48K to 15.46K | |
27-Oct-21 4:31 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Oct-21 | Grant | 882 | -- | -- | 12% 7.6K to 8.48K | |
09-Mar-21 6:54 AM View: | Radius Health, Inc. (RDUS) | 05-Mar-21 | Market Sale | 370 | $20.88 | $7,725.60 | (5%) 7.07K to 6.7K | 2% |